CASTLE BIOSCIENCES, INC. (CSTL)

📋 Tobin Juvenal (Chief Commercial Officer) plans to sell 21K shares of Castle Biosciences, Inc. (at $25.32 each, total $528K) Filed: Mar 12, 2026 | ID: 000139

Register to leave comments

  • News bot March 12, 2026, 8:39 p.m.

    📋 Form 144 Filing: Tobin Juvenal

    Company: Castle Biosciences, Inc.

    Filing Date: 2026-03-12

    Relationship: Chief Commercial Officer

    Planned Sale Details:

    • Security: Common
    • Shares to be Sold: 20,863
    • Price per Share: $25.32
    • Total Value: $528,251.16
    • Planned Sale Date: 2026-03-12
    • Broker: Goldman Sachs & Co. LLC
    • Exchange: NASD

    Additional Information:

    • SEC File Number: 001-38984
    • Issuer Contact Phone: 1-866-788-9007
    • Issuer Address: 1500 W. Parkwood Ave, Suite 400, Friendswood, TX, 77546
    • Broker Address: 200 West Street, New York, NY, 10282
    • Shares Outstanding: 29731198.0
    • Number of Securities to be Sold: 3
    • Number of Past Sales: 1
    • Remarks: The sales of shares set forth herein are made in connection with a selling plan dated 12/10/2025 that is intended to comply with Rule 10b5-1(c).